Dialysis-associated arthropathy — Role of age

Gutman RA. Characteristics of long term (14 years) survivors of maintenance dialysis. Nephron 1983: 33: 111–5.PubMedGoogle Scholar

Brown EA, Gower PE. Joint problems in patients on maintenance hemodialysis. Clin Nephrol 1982; 1: 247–50.Google Scholar

Brown EA, Arnold IR, Gower PE. Dialysis arthropathy: complication of long term treatment with hemodialysis. Br Med J 1986: 292: 163–6.Google Scholar

Hurst NP, Van den Berg R, Disney A, Alcock M, Albertyn L, Green M, Pascoe V. Dialysis-related arthropathy: a survey of 95 patients receiving chronic haemodialysis with special reference to β₂-microglobulin related amyloidosis. Ann Rheum Dis 1989; 48: 409–20.PubMedGoogle Scholar

Kessler M, Netter P, Azoulay E, Mayeux D, Péré P, Gaucher A. Dialysis-associated arthropathy: a multicentre survey of 171 patients receiving haemodialysis for over 10 years. Br J Rheumatol 1992; 31: 157–62.PubMedGoogle Scholar

Gejyo F, Yamada T, Odani S. A new form of amyloid protein associated with chronic hemodialysis was identified as β₂-microglobulin. Biochem Biophys Res Commun 1985; 129: 701–6.PubMedGoogle Scholar

Munoz-Gomez J, Bergada-Barado E, Gomez-Perez R, Llopart-Buisan E, Subias-Sobrevia E, Rotes-Querol J et al. Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: a new complication. Ann Rheum Dis 1985; 44: 729–33.PubMedGoogle Scholar

Van Ypersele do Strihou C, Honhon B, Vandenbroucke Huaux JP, Noël H, Maldague B. L'amylose du dialysé. Actual Nephrol Hôp Necker 1987: 371–89.Google Scholar

Bardin T, Zingraff J, Kuntz D, Drueke T. Dialysis-related amyloidosis. Nephrol Dial Transplant 1986; 1: 151–4.PubMedGoogle Scholar

Bardin T, Vasseur M, Vernejoul MC, Raymond P, Lafforgue B, Judith C et al. Etude prospective de l'atteinte articulaire des malades dialysés depuis plus de 10 ans. Rev Rheum 1984; 55: 131–4.Google Scholar

Kessler M, Cao Huu T, Amathally D, Chanliau J, Netter P, Péré P et al. Manifestations osté-articulaires du dialysé de plus de 70 ans. Nephrologie 1990; 11: 319–322.PubMedGoogle Scholar

Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent haemodialysis. Postgraduate Med J 1975: 51: 450–2.Google Scholar

Gejyo F, Homma N, Saito H, Arakawa M. Carpal tunnel syndrome and β₂-microglobulin amyloidosis: histological and biochemical aspects. In Gejyo F (ed): Dialysis amyloidosis. Milan, Wichtig, 1989 pp. 35–56.Google Scholar

Claudon M, Regent D, Gaucher A, Kessler M, Fabre JL, Grignon B et al. MR patterns of dialysis arthropathy. J Comput Assist Tomo 1990; 14: 968–74.Google Scholar

Laurent G, Charra B, Calemard E, Uzan M, Vanel T, Terrat JC et al. Mesure échographique de l'épaississement synovial de la hanche: intérêt dans l'évaluation de l'arthropathie des dialysés. Presse Méd 1989; 18: 939.Google Scholar

Kay J. Benson CB, Lester S, Corson JM, Pinkus GS, Lazarus JM et al. Utility of high-resolution ultrasound for the diagnosis of dialysis-related amyloidosis. Arthritis Rheum 1992; 35: 926–32.PubMedGoogle Scholar

Kuntz D, Naveau B, Bardin T, Drueke T, Treves R, Drylic A. Destructive spondylarthropathy in hemodialyzed patients: a new syndrome. Arthritis Rheum 1984; 27: 369–75.PubMedGoogle Scholar

Kessler M. Netter P, Grignon B, Bertheau JM, Aymard B, Azoulay E et al. Destructive β₂-microglobulin amyloid arthropathy of the cervico-occipital hinge in a hemodialyzed patient. Arthritis Rheum 1990; 33: 602–4.PubMedGoogle Scholar

Allard JC, Artze ME, Porter G, Ghandur-Miraymneh L, de Velasco R, Perez GO. Fatal destructive cervical spondylarthropathy in two patients on long-term dialysis. Am J Kidney Dis 1992; 19: 81–5.PubMedGoogle Scholar

Assenat H, Calemard E, Charra B, Laurent G, Terrat C, Vanel T. Hemodialyse, syndrome du canal carpien et substance amyloide. Nouv Presse Med 1980; 9: 1715.Google Scholar

Gorevic PD, Casey TT, Stone WJ, Diraimondo CR, Prelli FC, Frangione B. β₂-microglobulin is an amyloidogenic protein in man. J Clin Invest 1985; 76: 2425–9.PubMedGoogle Scholar

Bardin T, Kuntz D, Zingraff J, Voisin MC, Zelmar A, Lansaman J. Synovial Amyloidosis in patients undergoing long term hemodialysis. Arthritis Rheum 1985; 28: 1052–8.PubMedGoogle Scholar

Ohashi K, Hara M, Kawai R. Oguza Y, Honda K, Nihei H et al. Cervical discs are most susceptible to β₂-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992; 41: 1646–52.PubMedGoogle Scholar

Ogawa H, Saito A, Hirabayashi N, Hara K. Amyloid Deposition in systemic organs in long-term hemodialysis patients. Clin Nephrol 1987; 28: 199–204.PubMedGoogle Scholar

Campistol JM, Cases A, Torras A, Soler M, Munoz-Gomez J, Montolin J et al. Visceral involvement of dialysis anyloidosis. Am J Nephrol 1987; 7: 390–3.PubMedGoogle Scholar

Noël LH, Zingraff J, Bardin T, Atienza C, Kuntz D, Drüeke T. Tissue distribution of dialysis amyloidosis. Clin Nephrol 1987; 27: 175–8.PubMedGoogle Scholar

Zingraff J. Noël LH, Bardin T, Kuntz D, Dubost C, Drüeke T. β₂ microglobulin amyloidosis a sternoclavicular joint biopsy in hemodialysis patients. Clin Nephrol 1990; 33: 94–7.PubMedGoogle Scholar

Homma N, Gejyo F, Kobayashi H, Saito H, Sakai S, Suzuki M et al. Cystic radioluciencies of carpal bone, distal radius and ulna as a marker of dialysis-associated amyloid osteo-arthropathy. Nephron 1992; 62: 6–12.PubMedGoogle Scholar

Van Ypersele de Strihou C, Jadoul M, Melghem J. Maldague B, Jamart J and the working party on dialysis amyloidosis. Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991; 39: 1012–9.PubMedGoogle Scholar

Nelson SR, Hawkins PN, Richardson S, Lavender JP, Sethi D, Gower PE et al. Imaging of haemodialysis-associated amyloidosis with¹²³Iserum amyloid component. Lancet 1991; ii: 335–9.Google Scholar

Floege J, Burchert W, Brandis A, Gielow P, Nonnast-Daniel B, Spindler A et al. Imaging of dialysis-related amyloid (AB0-Amyloid) deposits with¹³¹1-β₂ microglobulin. Kidney Int 1990; 38: 1169–75.PubMedGoogle Scholar

Gaucher A, Kessler M. Netter P. Dialysis-associated arthropathy. Can we prevent it? Can it be treated? J Rheumatol 1992; 19: 1659–62.PubMedGoogle Scholar

King MS, Mi CC, Petersen J. In vivo effet of β₂-microglobulin on bone resorption in Mice. Kidney Int 1990; 37: 304 (abstract).Google Scholar

Kataoka H, Gejyo F, Yamada S. Inhibitory effects of β₂-microglobulin on in vitro calcification of osteoblastic cells. Biochem Biophys Res Commun 1986; 141: 360–6.PubMedGoogle Scholar

Brinkerhoff CE, Mitchell TI, Karmilowicz MJ, Kluve-Beckerman B, Benson MD. Autocrine induction of collagenase by serum amyloid-like and β₂-microglobulin-like protein. Science 1989; 243: 655–7.PubMedGoogle Scholar

Homma N, Gejyo F, Isemura M, Arakawa M. Collagen binding affinity of β₂-microglobulin, a preprotein of hemodialysis-associated amyloidosis. Nephron 1989; 53: 37–40.PubMedGoogle Scholar

Alcalay M, Goupy MC, Azais J, Boutoux D. Hemodialysis is not essential for the development of destructive spondylarthropathy in patients with chronic renal failure. Arthritis Rheum 1987; 30: 1182–6.PubMedGoogle Scholar

McCarthy JT., Dahlberg PJ, Kriegshauer JS, Valente RM, Swee RG, O'Duffy JD et al. Erosive spondylarthropathy in long-term dialysis patients. Relationship to severe hyperparathyroidism. Mayo Clin Proc 1988; 63: 446–52.PubMedGoogle Scholar

Kaplan P, Resnick D, Murphey M Heck L, Phalen J, Egan D et al. Destructive noninfectious spondylarthropathy in hemodialysis patients; a report of four cases. Radiology 1987; 161: 241–4.Google Scholar

Netter P, Kessler M, Burnel D, Hutin MF, Delons S, Benoit J et al. Aluminum in the joint tissues of chronic renal failure patients treated with regular homodialysis and aluminum compounds. J. Rheum 1984; 11: 66–70.PubMedGoogle Scholar

Netter P, Kessler M, Gaucher A, Gillet P, Delons S, Burnel D et al. Aluminium and dialysis arthropathy. Lancet 1988; i: 886–7.Google Scholar

Delongeas JL, Netter P, Boz P, Faure G, Roger RJ, Gaucher A. Experimental synovitis induced by aluminium phosphate in rabbits, Biomed Pharmacother 1984; 138; 44–8.Google Scholar

Netter P, Fener P, Steimetz J, Burnel D, Gillet P, Gaucher A et al. Amorphous aluminosilicates in synovial fluid in dialysis-associated arthropathy. Lancet 1991; i: 554–5.Google Scholar

Mitrovic DR, Stankovic A, Front P, Kuntz D. La toxicité de l'aluminium sur les tissus est-elle due à la production de radicaux libres d'oxygène? Presse Med 1987; 16: 1702.Google Scholar

Cary NRB, Sethi D, Brown EA, Erhardt CC, Woodrow DF, Gower PE. Dialysis arthropathy: amyloid or iron? Br Med J 1986; 293: 1392–4.Google Scholar

Sethi D, Woodrow DF, Brown EA, Cary NRB, Erhardt CC, Allard SA et al. β₂-microglobulin derived amyloid and iron in dialysis arthropathy. Nephrol Dial Transplant 1987; 2: 449 (abstract).Google Scholar

Floege J, Schäffer J, Koch K, Shaldon S. Dialysis related amyloidosis: a disease of chronic retention and inflammation. Kidney Int 1992; 42 (suppl 38) S78-S85.Google Scholar

Ozasa H, Chichibu K, Tanaka Y, Kondo T, Kitajima K, Ota K. Relationship between plasma levels of hyaluronic acid and amyloid-associated osteoarthropathy in chronic hemodialysis patients. Nephron 1992; 61: 187–91.PubMedGoogle Scholar

Jouzeau JY, Chary-Valckenaer I, Cao Huu T, Fener P, Netter P. Gaucher A et al. Elevated circulating levels of hyaluronan in long-term hemodialysis patients with dialysis-associated arthropathy: what does it mean? Nephron 1993; 64: 498–9.PubMedGoogle Scholar

Miyasaka N, Sato K, Kitano Y, Higaki M, Nishioka K, Ohta K. Aberrant cytokine production from tenosynovium in dialysis-associated amyloidosis. Ann Rheum Dis 1992; 51: 797–802.PubMedGoogle Scholar

Miura Y, Ishiyama T, Inomata A, Takeda T, Senma S, Okuyama K et al. Radiolucent bone cysts and the type of dialysis membrane used in patients undergoing long-term hemodialysis. Nephron 1992; 60: 268–73.PubMedGoogle Scholar

Brunner FP, Brynger H, Enrich JHH, Fassbinder W, Geerlings W, Rizzoni G et al. Case control study on aialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA registry. Nephrol Dial Transplant 1990; 5: 432–6.PubMedGoogle Scholar

Kessler M, Netter P, Maheut H, Wolf C, Prenat E, Cao Huu T. et al. Highly permeable and biocompatible membranes and prevalence of dialysis-associated arthropathy. Lancet 1991; i: 1092–3.Google Scholar

Cornelis F, Bardin T, Faller B, Verger C, Allouache M, Raymond P et al. Rheumatic syndromes and β₂-microglobulin amyloidosis in patients receiving long-term peritoneal dialysis. Arthritis Rheum 1989; 32: 785–8.PubMedGoogle Scholar

Digenis G, Davidson G, Dombros N, Katz A, Bookmann A, Oreopoulos D. Destructive spondylarthropathy in a patient on CAPD for 13 years. Perit Dial Inter. 1993; 13: 228–31.Google Scholar

Zingraff J, Noël LH, Bardin T, Atienza C, Zins B, Drüeke T et al. β₂-microglobulin amyloidosis in chronic renal failure. N Engl J Med 1990; 323: 1070–1.PubMedGoogle Scholar

Morinière Ph, Marie A, El Eser N, Fardellone P, Deramond H, Remond A et al. Destructive spondylarthropathy with β₂-microglobulin amyloid deposits in a uremic patient before chronic hemodialysis. Nephron 1991; 59: 654–7.PubMedGoogle Scholar

Gaucher A, Kessler M, Netter P, Azoulay E, Péré P, Mur JM. Dialysis arthropathy: the effect of age. J Rheumatol 1988; 15: 1880–1.PubMedGoogle Scholar

Stein G, Schneider A, Thoss K, Ritz E, Linke RP, Schaefer K et al. β₂-microglobulin derived amyloidosis onset, distribution and clinical features in 13 hemodialysed patients. Nephron 1992; 60: 274–80.PubMedGoogle Scholar

Egan MS, Goldenbard DL, Cohen AJ, Segal D. Association of amyloid deposits and osteoarthritis. Arthritis Rheum 1982; 25: 204–8.PubMedGoogle Scholar

Ohishi H, Skinner M, Sato-Araki N, Okuyama T, Gejyo F, Kimura A et al. Glycosaminoglycans of the hemodialysis — associated carpal synovial amyloid and of amyloid.-rech tissues and fibrils of heart, liver and spleen. Clin Chem 1990; 36: 88–91.PubMedGoogle Scholar

Zingraff J, Drüeke T. Can the nephrologist prevent dialysis-related amyloidosis? Am J Kidney Dis 1991; 18: 1–11.Google Scholar

Okutsu I, Nihomiya S, Takatori Y, Hamahaka I, Takemura Y, Otsubo K et al. Endoscopic management of shoulder pain in long-term haemodialysis patients. Nephrol Dial Transplant 1991; 6: 117–9.PubMedGoogle Scholar

Jadoul M, Malghem J, Pirson Y, Maldague B, Van Ypersele de Strihou C. Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy. Clin Nephrol 1989; 32: 194–7.PubMedGoogle Scholar

Jadoul M, Maldague B, Pirson Y, Van Ypersele de Strihou C. Renal transplantation for dialysis arthropathy. Lancet 1988; ii; 849.Google Scholar

Campistol JM, Munoz-Gemez J, Oppenheimer F, Ricard MJ, Vilardell J, Andreu J. Renal transplantation for dialysis arthropathy. Lancet 1988; ii: 900.Google Scholar

Kessler M, Netter P, Delons S, Grignon B, Cao Huu T, Chanliau J et al. Complications articulaires chez les insuffisants rénaux chroniques hémodialysés depuis plus de 10 ans. Presse Med 1988; 17: 679–82.PubMedGoogle Scholar

Gejyo F, Arakawa M. New perspectives in dialysis amyloidosis. In Gejyo F (ed): Dialysis amyloidosis. Milano Wichtig 1989; 147–153.Google Scholar

Revillard JP, Vincent C, Ramackers JM. β₂-microglobulin: structure, metabolism and alterations in diseases. In Gejyo F (ed): Dialysis-amyloidosis. Milano Wichtig 1989; 7–33.Google Scholar

Akizawa T, Kinugasa E, Kitaoka T, Koshikawa S, Nakahayashi N, Watanabe H et al. Removal of β₂-microglobulin by direct hemoperfusion with a newly developed absorbent. Trans Am Soc Aftif Organs 1987; 23: 532–7.Google Scholar

Morris GE, Jamieson NV, Small J, Evans DB, Calne R. Cadaveric Renal transplantation in elderly patients: is it worthwhile? Nephrol Dial Transplant 1991: 6: 887–92.PubMedGoogle Scholar

Cantarovich D, Baranger T, Baatard R, Tirouvanziam A, Lesant JN, Hourmant M et al. Cadaveric renal transplantation in patients older than 60 years of age. Ger Nephr Urol 1993; 3: 1–5.Google Scholar